LEXINGTON, Mass. and AMSTERDAM, May 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...

Scalable Platform for Integrated Research & Evidence — a new model for post-approval and late-stage clinical studies designed to help sponsors generate prospective clinical evidence faster, more ...

SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, ...

This study is led by Professor Xin Sun (Institute of Integrated Traditional Chinese and Western Medicine and Chinese Evidence-based Medicine Center, Cochrane China and IDEAL China Center, West China ...

Stellate Ganglion Blockade (SGB) is increasingly recognized as a significant therapeutic modality in the treatment of various clinical disorders, including regional pain syndromes, autonomic ...

In the MAD phase, participants will receive once-daily oral dosing of NTX-253 or placebo for 10 consecutive days, with ...

Clinical studies remain one of the most difficult phases in medical device development. They’re slow, expensive, and sometimes unpredictable — but completely necessary for nearly everything that ...

6 Health and Social Research Center, Universidad de Castilla La-Mancha, Cuenca, Spain Objective To examine the predictive validity of field-based muscular strength tests in relation to incident ...

Neuroscientists from Monash University, the University of Melbourne and University College London are calling for clinical ...

Xenon Pharmaceuticals provided an update on its pipeline programs, highlighting significant progress and upcoming milestones for 2025. The company anticipates topline data from its first Phase 3 study ...